PATRYS LIMITED

ASX: PAB
Sector
Sector:Health Care
Industry group
Industry:Pharmaceuticals, Biotechnology & Life Sciences

PAB Share Price

PAB News & Analysis

PABHealth CareCompany Update22 Oct 2026· 2 min read

Patrys Limited (ASX: PAB) Advances RLS-2202 Trial to Cohort 2

Patrys has advanced intravenous delirium candidate RLS-2202 into Cohort 2 after an acceptable initial safety review. The next cohort will compare its pharmacokinetics with oral quetiapine.

Latest PAB ASX Announcements

  1. 11 Nov 2026 · 6:36 pmOther
  2. 9 Nov 2026 · 6:08 pmSubstantial Holders
  3. 9 Nov 2026 · 6:04 pmDirector Interests
  4. 9 Nov 2026 · 6:00 pmSecurities Administration
  5. 9 Nov 2026 · 5:58 pmSecurities Administration
  6. 30 Oct 2026 · 8:06 amMeetings & Governance
  7. 30 Oct 2026 · 8:06 amMeetings & Governance
  8. 29 Oct 2026 · 8:11 amQuarterly Reports
  9. 22 Oct 2026 · 8:18 amCompany Update
  10. 13 Oct 2026 · 8:12 amPresentations
  11. 6 Oct 2026 · 10:26 amPresentations
  12. 5 Oct 2026 · 7:34 pmMeetings & Governance
  13. 30 Sept 2026 · 4:53 pmSecurities Administration
  14. 29 Sept 2026 · 8:13 amCompany Update
  15. 28 Sept 2026 · 5:32 pmFinancial Results
View complete PAB announcement history →